As of 2025-09-18, the Relative Valuation of Aerie Pharmaceuticals Inc (AERI) is (15.07) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.25 USD, the upside of Aerie Pharmaceuticals Inc based on Relative Valuation is -198.8%.
The range of the Relative Valuation is (14.94) - (15.19) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.8x - 20.5x | 19.6x |
| Forward P/E multiples | 20.2x - 22.2x | 21.2x |
| Fair Price | (14.94) - (15.19) | (15.07) |
| Upside | -198.0% - -199.6% | -198.8% |
| Date | P/E |